Literature DB >> 19029323

First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Shiri Navon-Venezia1, Azita Leavitt, Mitchell J Schwaber, J Kamile Rasheed, Arjun Srinivasan, Jean B Patel, Yehuda Carmeli.   

Abstract

A highly epidemic carbapenem-resistant clone of KPC-3-producing Klebsiella pneumoniae emerged in Israel in 2006, causing a nationwide outbreak. This clone was genetically related to outbreak strains from the United States isolated in 2000 but differed in KPC-carrying plasmids. The threat of the global spread of hyperepidemic, extensively drug-resistant bacterial strains should be recognized and confronted.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19029323      PMCID： PMC2630632          DOI： 10.1128/AAC.00987-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  A clone of methicillin-resistant Staphylococcus aureus among professional football players.

Authors:  Sophia V Kazakova; Jeffrey C Hageman; Matthew Matava; Arjun Srinivasan; Larry Phelan; Bernard Garfinkel; Thomas Boo; Sigrid McAllister; Jim Anderson; Bette Jensen; Doug Dodson; David Lonsway; Linda K McDougal; Matthew Arduino; Victoria J Fraser; George Killgore; Fred C Tenover; Sara Cody; Daniel B Jernigan
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

4.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors:  Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal:  Arch Intern Med       Date:  2005-06-27

5.  Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates.

Authors:  Ellen Smith Moland; Nancy D Hanson; Vicki L Herrera; Jennifer A Black; Thomas J Lockhart; Ashfaque Hossain; Judith A Johnson; Richard V Goering; Kenneth S Thomson
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

6.  High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.

Authors:  Rong Zhang; Lijiang Yang; Jia Chang Cai; Hong Wei Zhou; Gong-Xiang Chen
Journal:  J Med Microbiol       Date:  2008-03       Impact factor: 2.472

7.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

8.  Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

Authors:  Azita Leavitt; Shiri Navon-Venezia; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.

Authors:  Zmira Samra; Orit Ofir; Yinon Lishtzinsky; Liora Madar-Shapiro; Jihad Bishara
Journal:  Int J Antimicrob Agents       Date:  2007-10-10       Impact factor: 5.283

10.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191
View more
  63 in total

1.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world.

Authors:  Christine Lascols; Meredith Hackel; Andrea M Hujer; Steven H Marshall; Sam K Bouchillon; Daryl J Hoban; Stephen P Hawser; Robert E Badal; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

3.  Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates.

Authors:  Kamaljit Singh; Kathy A Mangold; Kody Wyant; Donna M Schora; Barbara Voss; Karen L Kaul; Mary K Hayden; Vishnu Chundi; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

4.  Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258.

Authors:  Azita Leavitt; Inna Chmelnitsky; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

Review 5.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

6.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

7.  Imipenem disc for detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice.

Authors:  Shmuel Benenson; Violeta Temper; Matan J Cohen; Carmela Schwartz; Carlos Hidalgo-Grass; Colin Block
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

8.  Molecular Characterization of an Atypical IncX3 Plasmid pKPC-NY79 Carrying bla KPC-2 in a Klebsiella pneumoniae.

Authors:  Pak-Leung Ho; Yuk-Yam Cheung; Wai-U Lo; Zhen Li; Kin-Hung Chow; Chi-Ho Lin; Jasper Fuk-Woo Chan; Vincent Chi-Chung Cheng
Journal:  Curr Microbiol       Date:  2013-06-01       Impact factor: 2.188

9.  Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity.

Authors:  Ana M Rada; Elsa De La Cadena; Carlos Agudelo; Cesar Capataz; Nataly Orozco; Cristian Pallares; An Q Dinh; Diana Panesso; Rafael Ríos; Lorena Diaz; Adriana Correa; Blake M Hanson; Maria V Villegas; Cesar A Arias; Eliana Restrepo
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 10.  Carbapenemase-producing Enterobacteriaceae.

Authors:  Yohei Doi; David L Paterson
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.